
Linde India Q1 Results FY26: Q1 PAT Falls 5.72% to ₹107.19 Crore; Revenue Down 12.58% YoY
Q1 Results FY26
Updated: 11 Aug 2025 • 7:59 pm
Posted by:

Linde India Q1 Results FY26: Extracts of FY25 & FY26 (Consolidated Figures)
| Particulars | Quarter Ended | |
| 30-06-2025 | 30-06-2024 | |
| Revenue from Operations | ₹571.08 | ₹653.23 |
| Profit Before Tax (PBT) | ₹201.37 | ₹203.35 |
| Profit After Tax (PAT) | ₹107.19 | ₹113.69 |
(Figures in crores)
Linde India Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)
| Particulars | Quarter Ended | |
| 30-06-2025 | 30-06-2024 | |
| Revenue from Operations | ₹571.08 | ₹653.23 |
| Profit Before Tax (PBT) | ₹201.37 | ₹203.35 |
| Profit After Tax (PAT) | ₹105.07 | ₹111.54 |
(Figures in crores)
Linde India Q1 Results FY26 Highlights (Q1 FY26 vs FY25)
- Linde India clocked Q1 FY26 consolidated revenue of ₹571.08 crores vs ₹653.23 crores.
- On the profit front, Linde India earned a consolidated PAT of ₹107.19 crore in Q1 FY26. During FY25, the company’s PAT stood at ₹113.69 crore.
- Consolidated PAT fell for the first quarter of FY26, was 5.72% YoY, and revenue fell 12.58% YoY.
- As per the standalone figures, the quarterly PAT of Linde India has decreased by 5.80%, and revenue has decreased by 12.58% YoY.
Linde India Share Price Performance
On the opening bell of 11th August 2025, the shares of Linde India opened at ₹468.69 per share. However, the initial gains are sustained as of now, and Linde India shares are trading at ₹472.42 per share, higher than their opening price.
Considering the long-term performance, Linde India shares have yielded close to 5.74% returns in the past 1 year, and 5-year returns stand at 90.11%. Over the maximum timeframe, the Linde India share provided 5,895.18% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Linde India shares after thorough research.
For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Icodex Publishing Solutions IPO GMP: Day 1 IPO Live Updates
Bluestone Jewellery IPO GMP: Day 1 IPO Live Updates
Highway Infrastructure IPO Listing Preview: What to Expect Now in 2025?
Concord Biotech Q1 Results FY26: Q1 PAT Falls 26.07% to ₹44.06 Crore; Revenue Down 5.47% YoY
Sawaliya Foods Products IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Connplex Cinemas IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Mahendra Realtors IPO GMP & Review: Apply or Avoid?
Regaal Resources IPO GMP & Review: Apply or Avoid?
Icodex Publishing Solutions IPO GMP & Review: Apply or Avoid?
Recent Articles

Top Stocks to Buy for Long Term: Bharti Airtel, Kotak Bank, Eternal Among 9 Stocks Experts Suggest, Check Target Price
13 October 2026

Hong Kong Stock Market: Hang Seng Index Recovers From Intraday Losses, Extends Gains for 3rd Day, What Gave It a Boost?
13 October 2026

Ramkrishna Forgings Share Price Up 34% in 2026: Monarch Networth Sees 18% Upside With Rs 806 Target, Here's Why
13 October 2026

RIL Target Price Ahead of Jio Initial Public Offering: 47% Upside, Why Religare Recommends Buying the Mukesh Ambani Stock Before Issue Launch
13 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Top Stocks to Buy for Long Term: Bharti Airtel, Kotak Bank, Eternal Among 9 Stocks Experts Suggest, Check Target Price
Hong Kong Stock Market: Hang Seng Index Recovers From Intraday Losses, Extends Gains for 3rd Day, What Gave It a Boost?
Ramkrishna Forgings Share Price Up 34% in 2026: Monarch Networth Sees 18% Upside With Rs 806 Target, Here's Why
RIL Target Price Ahead of Jio Initial Public Offering: 47% Upside, Why Religare Recommends Buying the Mukesh Ambani Stock Before Issue Launch
Moneyview Share Price: Newly Listed Stock Gives 83% Returns in 13 Days, Should You Hold for More Gains or Book Profits?
Popular this week
Up 75% in 6 Months, India Glycols Shares Surge 14% Today: Should You Buy? Experts Decode the India Glycols Share Price Rally

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





